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Peripheral Blood Cell Counts as Potential Biomarkers for Alzheimer’s Disease: A Look at Polygenetic
Risk Scores
Melika Cummings, Yimei Lu, Joan Manuel Cue, Neel Patel, Jenifer Do, Jingchun Chen
Blood-based biomarkers for neurodegenerative illnesses such as Alzheimer's
disease (AD) have been extensively researched. Alzheimer's disease (AD) is a
progressive neurological illness whose progression has been ascribed to gene
expression. However, the pathophysiology of these disorders and its relationship to
other abnormalities remain unknown. AD has been connected to PBCs, which
include erythrocytes, platelets, and leukocytes and have a complicated interaction
with the brain system. The pathogenesis of PBCs has been related to a negative
influence on established neurodegenerative illnesses such as Alzheimer's.
Candidate gene association studies have become more common as progress in
mapping the human genome has increased their viability. The plurality of candidate
genes were selected based on their function or expression in disease-related
systems (e.g., dopamine neurotransmitter systems), and this strategy is crucial for
defining the nature of internal disturbance. It has increasingly been postulated that,
in addition to cell-cell signaling inside the brain, dynamic crosstalk between the
brain and systemic mechanisms such as circulation of blood cells may be crucial.
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It is now well accepted that inflammation plays a significant role in the etiology of
Alzheimer's disease. Moreover, there is considerable neuroinflammation in the brain
parenchyma throughout AD progression, as well as peripheral inflammation with
active engagement of peripheral white blood cells such as T lymphocytes or
monocytes. Alzheimer's disease (AD) is the most common neurodegenerative ailment
and one of the most serious socioeconomic issues in the industrialized world. Since
neuroinflammation is frequently caused by the interplay of defense mechanisms shared
by all white blood cells, there is a risk of neurodegeneration from chronic stimulation
of these blood cells.
There is a potential of a link between Alzheimer's disease and LYM counts since
people with Alzheimer's disease have greater levels of activated lymphocytes.
Alzheimer's disease susceptibility is governed by both single-gene and polygenic risk
factors, as well as environmental exposure. These results indicate that under some
situations, peripheral immune cells can pass the blood-brain barrier. Biomarkers should
ultimately be able to detect the molecular basis of both neuropathological alterations
and the development of dementia. In Alzheimer's disease, several peripheral cells,
including platelets, erythrocytes, and lymphocytes, undergo physiologic alterations. A
high neutrophil population is commonly associated with the onset, progression, and
severity of inflammation in Alzheimer's disease patients.

Objectives: To identify whether the genetic risk scores of peripheral blood count
scores are associated with AD.
PRS of Neutrophil Count vs AD

PRS of White Blood Cell Count vs AD

We carefully selected optimal P-value thresholds to strike a compromise between our
ability to discover unique rare variants and a low false-positive rate. We sought to
address the limitation of low discovery power by incorporating validation data from a
separate case-control research, but all of the main insights given here should be
deemed preliminary until verified in additional data sets. Only by creating and
analyzing bigger data sets, particularly in white blood cells, and investigating these and
other unusual alterations in relation to AD susceptibility will we be able to distinguish
true from falsified discoveries.

Source: Xie, J. et al. (2021).

Methods

Future Implications

Figure 1: Bar Plots of PRS of Blood Cells vs AD. The x-axis shows 9 distinct p-value
criteria produced by PRSice-2's fast-score option. Nagelkerke's R-squared is represented
by R2, and the numbers at the top of the bars are the p-values for that threshold.

Findings
Using our polygenic analysis was generated using PRSice-2. The PRS was significantly
different between cases and controls (Fig. 1) with a best p-threshold of varied values
between the different traits. Figure 1 shows the explained variance (y-axis) for each
p-threshold (x-axis) to identify cases and controls for our sample. The thresholds for all
traits held p-values that were very significant. In monocytes (MONO), lymphocytes
(LYM), and white blood cells (WBC); the best threshold were leaning to more inclusive
values. This meant that there were more samples being read compared to the lowest
threshold value (Table 1). For neutrophil (NEU) cells, the best threshold value was much
more exclusive.
Blood Cell Type
MONO
LYM
WBC
NEU

Threshold

R2

P

Reg. Coeff.

SE

# of SNPs

0.288
0.041
0.347
0.006

0.007
0.006
0.004
0.005

4.87E-04
6.68E-04
5.23E-03
3.17E-03

5878.130
-3129.910
-10781.700
2984.920

1685.330
919.889
3861.270
1011.560

226311
77131
252923
26115

Further study into trait-specific genomic analysis of peripheral blood cell counts may
give insights into the role of white blood cell regulatory pathways in AD pathogenesis.
This study will assist investigators in determining if peripheral blood cell
concentrations impact neuroinflammation and phagocytosis, which frequently promote
to neurodegenerative development. We anticipate that additional descriptive statistics
and work on blood-based biomarkers will lead to a better understanding of AD
pathology. Currently, our team has focused on examining new analytic approaches,
such as MR analysis. With further advancement, this initiative may have an influence
on the creation of a novel target for AD treatment and disease progression prediction.
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